The authors reply: To the Editor: Drs. Chahine and Raizner raise several important questions concerning the pathophysiologic mechanisms of systolic anterior motion of the mitral valve (SAM) and IHSS-type hemodynamics. In a clinical situation it may not be possible to differentiate SAM causing left ventricular outflow obstruction from a rapid left ventricular ejection rate causing an outflow gradient, causing SAM. Indeed, the mechanism of the outflow gradient in IHSS has not been conclusively proven. The distinction between these two proposed mechanisms may be moot becauses in IHSS ventricular emptying is completed in early systole before the gradient is most manifest.' The difference between gradient and obstruction may be a matter of semantics.
Second, the measurement of septal thickness is often difficult because right ventricular chordal structures can obscure the true right side of the septum. The septum may appear thicker than it really is. Contrast echocardiography has been used to define the true right side of the septum in two cases of SAM without asymmetric septal hypertrophy (ASH).2 Difficulty in defining septal thickness is somewhat less of a problem with two-dimensional echocardiography. Three of our patients had two-dimensional studies. Septal thicknesses and densities were normal in contrast to the patterns of increased septal thickness and abnormal septal density characteristic of IHSS.3 Thallium imaging has shown normal septal thickness in patients with SAM but without ASH.4 One of these patients had a normal septal thickness at autopsy. We have also recently seen another patient with SAM but without ASH who, at autopsy, had a normal septal thickness.
We have no explanation for the discrepancy between normal echocardiographic septal thickness and electrocardiographic evidence of left ventricular hypertrophy (LVH). Two comments, however, may be pertinent. First, ECG criteria for LVH correlate best with overall left ventricular mass. At issue in the diagnosis of IHSS is the presence or absence of localized ASH. Second, false positives in the diagnosis of LVH are inherent in any of the ECG criteria used.
The discrepancy between figure 6 and proposals3 to increase the stored energy of direct-current defibrillators. One issue not addressed by the authors, however, is the distinction between availability and use of the more powerful devices. Proponents argue that higher energy would only be used for the occasional very large or acidotic patient who might require it. Drs. DeSilva and Lown presumably fear that maximal energy would still be used routinely, as it is now. If so, the resultant myocardial damage in many would outweigh the unproven benefits for a few. Such an assumption is supported by the history of the indiscriminate application of similar technological advances in medicine. 4 One's stance in this debate, then, is likely to reflect one's degree of confidence in the clinical judgement of. technologically-minded young physicians and other trained resuscitators. No relevant data are available, but there is an old Yankee tale which dramatizes this pointnamely, that practitioners of all trades tend to be overly enthusiastic about their own services.
A travelling minister went "down east" in Maine (or up-country in Vermont) to conduct services. Only one person attended and the minister was hesitant to go on, to which the old timer dryly objected, "Reverend, when I take my wagonful of hay out to feed my cows, and only one shows up, I don't let her down." Duly impressed, the minister proceeded with his usual two-hour hellfire and damnation sermon, finally pausing to accept some congratulations. "Reverend," said the old timer after a long pause, "when I take my wagon out to feed my cows, and only one shows up, I don't give her the whole damn load!" Are we as judicious as the farmer, or rather more like the minister? My hunch favors the latter. The tail of technology will probably continue to wag the dog.
End-Systolic Pressure-Volume Relations
To the Editor:
The recent article by Grossman et al.1 is the first full paper about end-systolic pressure-volume ratio as a new index for cardiac contractility studied on human subjects. I have long been interested in experimental studies on end-systolic pressure-volume or force-length relations, and I am happy to see the theory beautifully applied in the clinical study.
More than half of the patients studied (11 out of 19) had mitral regurgitation; the grade was not indicated. In mitral insufficiency the smallest left ventricular volume or maximum shortening of the muscle fibers occurs at the opening of mitral valve. This provokes two problems. I) To take simultaneous pressure and volume, the pressure should be measured at the mitral valve opening instead of at the dicrotic notch of aortic pressure. The use of dicrotic notch pressure mightly partly explain the small variation of pressure in contrast to wide volume changes.
2) More important, there is uncertainty about contact of pressure-volume curve with active pressure-volume line at end-systole in mitral valve incompetence. I agree that the mechanical state at the point of maximum shortening of muscle fibers, or the smallest ventricular volume, depends solely on contractility, irrespective of contraction course; that is, irrespective of afterload offered by systemic pressure or left atrial pressure. The mitral valve opening occurs, however, at the relaxation phase; more precisely, close to the end of the phase. Therefore, it is rather difficult to understand that the state at almost complete relaxation corresponds to "active" pressurevolume line which is usually constructed by full active contraction, though relaxation process has recently proved to be influenced by contractility. As relaxation process starts during ejection phase, the end-systolic point could deviate from the active pressure-volume line in case of too long ejection time.
Thus, there is some doubt about unanimous identity of endsystolic pressure-volume line with active pressure-volume line, especially in mitral regurgitation. MASAHIKO 
